A population-based comprehensive lifestyle intervention to promote healthy weight and physical activity in people with cardiac disease

Not Applicable

Completed

• Conditions: acute coronary syndrome; coronary artery bypass graft surgery; myocardial infarction; percutaneous coronary intervention; Cardiovascular - Coronary heart disease

• Registration Number: ACTRN12610000102077
• Lead Sponsor: South East Sydney & Illawarra Area Health Service

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-02-02
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 356

Inclusion Criteria

All people referred for cardiac rehabilitation at two urban and two regional hospitals from the commencement of the trial.

Exclusion Criteria

Unable to use English fluently enough to participate in the interview or telephone coaching calls.

A clinical diagnosis of uncompensated, severe cardiac failure (Class IV); uncontrolled arrhythmia or angina; severe or symptomatic aortic stenosis; or persistent hypotension with systolic blood pressure (SBP) <90 mm Hg.

A clinical diagnosis of a severe coexisting medical condition that would prevent participation eg. Cognitive impairment, dementia, a terminal illness, severe rheumatoid arthritis, severe arthritis, renal disease requiring dialysis, uncontrolled diabetes.

Are planning to have major orthopaedic surgery within the next 6 months that is likely to affect their mobility eg. hip replacement; knee reconstruction; spinal surgery.

A signed consent form is not returned.

A signed clearance form is not returned from their general practitioner or specialist.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Primary Outcome 1: Proportion of participants achieving a healthy weight as defined by the National Heart Foundation of Australia. Weight will be assessed by self-report. In a sub-group, objective measures of height and weight will be completed by the researchers at baseline and at 8 months.[Timepoint: at baseline, 8 weeks and 8 months for the intervention group. At baseline, 6 weeks and 6 months for the control group.]